Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (171-180 of 292) with videos related to

Pageof 30
Sort By:
Clinical Genitourinary Cancer|December 31, 2024
A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)Michael Staehler, Umberto Basso, Jean-Christophe Eymard, et al.
Urologic Oncology|March 15, 2016
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomyHarun Fajkovic, Romain Mathieu, Ilaria Lucca, et al.
World Journal of Urology|December 28, 2014
Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomyGiuseppe Simone, Marco Bianchi, Diana Giannarelli, et al.
BJU International|March 8, 2013
Gender-specific effect of smoking on upper tract urothelial carcinoma outcomesMichael Rink, Evanguelos Xylinas, Quoc-Dien Trinh, et al.
European Urology|December 5, 2012
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomyMichael Rink, Emily C Zabor, Helena Furberg, et al.
The Journal of Urology|June 28, 2021
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical CystectomyVictor M Schuettfort, Benjamin Pradere, David D'Andrea, et al.
BJU International|March 5, 2016
Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional studyRomain Mathieu, Ilaria Lucca, Mihai D Vartolomei, et al.
World Journal of Surgical Oncology|June 15, 2020
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinomaTill Eichenauer, Navid Shadanpour, Martina Kluth, et al.
European Urology Focus|October 28, 2017
Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European SurveyKees Hendricksen, Atiqullah Aziz, Perrine Bes, et al.
BJU International|September 15, 2017
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre studyMalte W Vetterlein, Philipp Gild, Luis A Kluth, et al.
Pageof 30

Showing results (171-180 of 292) with videos related to

Sort By:
Pageof 30
Clinical Genitourinary Cancer|December 31, 2024
A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)Michael Staehler, Umberto Basso, Jean-Christophe Eymard, et al.
Urologic Oncology|March 15, 2016
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomyHarun Fajkovic, Romain Mathieu, Ilaria Lucca, et al.
World Journal of Urology|December 28, 2014
Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomyGiuseppe Simone, Marco Bianchi, Diana Giannarelli, et al.
BJU International|March 8, 2013
Gender-specific effect of smoking on upper tract urothelial carcinoma outcomesMichael Rink, Evanguelos Xylinas, Quoc-Dien Trinh, et al.
European Urology|December 5, 2012
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomyMichael Rink, Emily C Zabor, Helena Furberg, et al.
The Journal of Urology|June 28, 2021
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical CystectomyVictor M Schuettfort, Benjamin Pradere, David D'Andrea, et al.
BJU International|March 5, 2016
Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional studyRomain Mathieu, Ilaria Lucca, Mihai D Vartolomei, et al.
World Journal of Surgical Oncology|June 15, 2020
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinomaTill Eichenauer, Navid Shadanpour, Martina Kluth, et al.
European Urology Focus|October 28, 2017
Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European SurveyKees Hendricksen, Atiqullah Aziz, Perrine Bes, et al.
BJU International|September 15, 2017
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre studyMalte W Vetterlein, Philipp Gild, Luis A Kluth, et al.
Pageof 30